The U.S. Food and Drug Administration has approved a once-weekly combined hormonal patch (CHC) with low-dose estrogen, Viatris Inc. announced last week.
Viatris’ patch, Gwyn Lo, is expected to be available later this year. It is applied weekly for three consecutive week followed by an off week.
It is contraindicated in women who smoke, over 30 BMI or are over 35...